Immunotherapy in mantle cell lymphoma: anti-CD20-based therapy and beyond. Jan 2008 - Am. J. Hematol.; 83(2):0361-8609 [PMID:17722077] [Zhou Y] [Zhang L] [Romaguera J] [Delasalle K] [Han X] [Du X] [Kwak L] [Yi Q] [Wang M]
Reversing adriamycin resistance of human breast cancer cells by hyperthermia combined with Interferon alpha and Verapamil. Aug 2007 - J. Exp. Clin. Cancer Res.; 26(2):0392-9078 [PMID:17725099] [Zhang L] [Yang Y] [Wei XY] [Shi YR] [Liu HY] [Niu RF] [Hao XS]
Antitumor immune response induced by i.t. injection of vector-activated dendritic cells and chemotherapy suppresses metastatic breast cancer. Aug 2006 - Mol. Cancer Ther.; 5(8):1535-7163 [PMID:16928818] [Akbulut H] [Tang Y] [Akbulut KG] [Maynard J] [Zhang L] [Deisseroth A]
Specific antihepatocellular carcinoma T cells generated by dendritic cells pulsed with hepatocellular carcinoma cell line HepG2 total RNA. Feb 2006 - Cell. Immunol.; 238(1):0008-8749 [PMID:16472793] [Zhang L] [Zhang H] [Liu W] [Wang H] [Jia J] [Si X] [Ren J]
Preparation of apoptotic tumor cells with replication-incompetent HSV augments the efficacy of dendritic cell vaccines. Feb 2006 - Cancer Gene Ther.; 13(2):0929-1903 [PMID:16138121] [Courrèges MC] [Benencia F] [Conejo-García JR] [Zhang L] [Coukos G]